Veradigm ( (MDRX) ) just unveiled an update.
On March 18, 2025, Veradigm announced the filing of its comprehensive Annual Report for the year ended December 31, 2022, with the SEC, which includes restated financial information. The company provided updates on its financial performance for fiscal years 2023 and 2024, and an outlook for 2025, highlighting estimated revenues, net income, and cash positions. Despite challenges, Veradigm remains focused on addressing internal control deficiencies, maintaining current financial reporting, and executing its growth strategy. The company anticipates flat revenue in 2025 compared to 2024, with positive net cash expected.
More about Veradigm
Veradigm is a healthcare technology company that offers data and technology solutions to healthcare providers, payers, and the biopharma market. It leverages its platforms, data, expertise, and connectivity to deliver advanced insights and data-driven solutions.
YTD Price Performance: -44.84%
Average Trading Volume: 463,895
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $890.1M
See more data about MDRX stock on TipRanks’ Stock Analysis page.